Over the course of 2024, we’ve seen all kinds of stories across surgical robotics, ranging from new systems to FDA clearances and more.
Excelsius robotic spine surgery system at work in 20 hospitals
The Excelsius Ecosystem is a robotic navigation platform that combines Globus Medical’s Excelsius 3D imaging system and ExcelsiusGPS.
Globus Medical acquires StelKast, develops robotic joint reconstruction system
Globus Medical, which is developing a system for robot-assisted joint replacement, has acquired medical device supplier StelKast.
7 companies transforming orthopedics with robot-assisted surgery
Orthopedic device companies have been actively developing products for surgical robotics, several through acquisitions.
Stryker strives for market share in orthopedic surgery robots
Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology.
Globus Medical jumps on FDA nod for Excelsius GPS robot-assisted surgery platform
Globus Medical (NYSE:GMED) said today that it won 510(k) clearance from the FDA for its long-awaited Excelsius robot-assisted surgery platform, which is designed to integrate intra-operative CT and fluoroscopic imaging technologies. Audubon, Pa.-based Globus said the clearance covers minimally invasive and open orthopedic and neurosurgical surgeries, including screw placement in spinal and orthopedic procedures. The system won CE…
Globus Medical acquires robotic surgical dev KB Medical, posts Q2 earnings
Globus Medical (NYSE:GMED) said today it acquired Swiss robotic developer KB Medical, and released 2nd quarter earnings that beat The Streets earnings per share expectations, but fell short of sales expectations. The company said it closed the acquisition of KB Medical during its 2nd quarter, and that the buy would help expand its imaging, navigation and…
FDA deals setback to Globus Medical’s ExcelsiusGPS robot-assisted surgery platform
Globus Medical (NYSE:GMED) said yesterday that the FDA won’t accept the 510(k) clearance bid for its ExcelsiusGPS robot-assisted surgery platform, likely delaying its launch until the 3rd quarter. Globus said in a regulatory filing that the federal safety watchdog told it that the company hadn’t “sufficiently addressed the FDA’s questions” about its original clearance application. Audubon, Pa.-based Globus…
Globus Medical wins CE Mark for Excelsius GPS robotic guidance device
Globus Medical (NYSE:GMED) said today that it won CE Mark approval in the European Union for the Excelsius GPS robotic guidance device it acquired 3 years ago. Audubon, Pa.-based Globus said the Excelsius GPS system is for use in both minimally invasive and open procedures for orthopedics and neurosurgery, including procedures for the spine, long bones…